Indoleamine 2,3-Dioxygenase Controls Fungal Loads and Immunity in Paracoccidioidomicosis but is More Important to Susceptible than Resistant Hosts

PLoS Neglected Tropical Diseases

Volumn 8, Issue 11, 2014, Pages

  Araújo, Eliseu F ^a   Loures, Flávio V ^a   Bazan, Silvia B ^a   Feriotti, Claudia ^a   Pina, Adriana ^a   Schanoski, Alessandra S ^a   Costa, Tânia A ^a   Calich, Vera L G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2, 3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; KYNURENINE; NITRIC OXIDE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; INDOLEAMINE 2,3 DIOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE RESISTANCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FUNGUS GROWTH; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; IMMUNOREGULATION; MORTALITY; MOUSE; MRNA EXPRESSION ASSAY; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SOFT TISSUE INFLAMMATION; SOUTH AMERICAN BLASTOMYCOSIS; SPECTROPHOTOMETRY; TH17 CELL; ANIMAL; DENDRITIC CELL; DRUG EFFECTS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY;

ANIMALS; CYTOKINES; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; HOST-PATHOGEN INTERACTIONS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; LUNG; MICE; PARACOCCIDIOIDOMYCOSIS;

EID: 84920531517     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003330     Document Type: Article

References (65)

1. Mellor AL, Munn DH, (1999) Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20: 469–473.
2. Ibana JA, Belland RJ, Zea AH, Schust DJ, Nagamatsu T, et al. (2011) Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells. Infect Immun 79: 4425–37.
3. Heyes MP, Chen CY, Major EO, Saito K, (1997) Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem J 326: 351–6.
4. Byrne GI, Lehmann LK, Landry GJ, (1986) Mechanism for gamma-interferon-mediated Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 53: 347–351.
5. Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762–74.
6. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Mellor AL, et al. (1999) Inhibition of T-cell proliferation by macrophage tryptophan catabolism. J Exp Med 189: 1363–1372.
7. Lanzinger M, Jürgens B, Hainz U, Dillinger B, Raberger J, et al. (2012) Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase. Eur J Immunol 42: 1117–28.
8. Munn DH, Sharma MD, Baban B, Harding HP, Mellor AL, et al. (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22: 633–42.
9. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, et al. (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9: 1069–77.
10. Platten M, Ho PP, Youssef S, Fontoura P, Steinman L, et al. (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310: 850–5.
11. Bauer TM, Jiga LP, Chuang JJ, Randazzo M, Terness P, et al. (2005) Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int 18: 95–100.
12. Fuchs D, Möller AA, Reibnegger G, Werner ER, Werner-Felmayer G, et al. (1991) Increased endogenous interferon-γ and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett 28: 207–211.
13. Boasso A, Shearer GM, (2007) How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr Drug Metab 8: 217–23.
14. Katz JB, Muller AJ, Prendergast GC, (2008) Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 222: 206–221.
15. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191–1193.
16. Divanovic S, Sawtell NM, Mellor AL, Munn DH, Karp CL, et al. (2012) Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis 205: 152–61.
17. Leonhardt RM, Lee S-J, Kavathas PB, Cresswell P, (2007) Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis. Infect Immun 75: 5105–17.
18. Yeung AWS, Wu W, Freewan M, Stocker R, King NJC, et al. (2012) Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-κB. J Leukoc Biol 91: 657–66.
19. Bozza S, Fallarino F, Pitzurra L, Zelante T, Montagnoli C, et al. (2007) Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 179: 5999–6008.
20. Bozza S, Fallarino F, Pitzurra L, Zelante T, Montagnoli C, et al. (2005) A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 174: 2910–8.
21. Romani L, Zelante T, Luca A De, Fallarino F, Puccetti P, (2008) IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 180: 5157–5162.
22. Montagnoli C, Fallarino F, Gaziano R, Bozza S, Bellocchio S, et al. (2006) Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 176: 1712–1723.
23. Romani L, (2008) Parasites and autoimmunity: the case of fungi. Autoimmun Rev 8: 129–33.
24. Barth H, Raghuraman S, (2014) Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy. Crit Rev Microbiol 40: 360–8.
25. Franco M, Montenegro MR, Mendes RP, Marques Dillon NL, et al. (1987) Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop 20: 129–32.
26. Mamoni RL, Blotta MHSL, (2005) Kinetics of cytokines and chemokines gene expression distinguishes Paracoccidioides brasiliensis infection from disease. Cytokine 32: 20–9.
27. Benard G, Romano CC, Cacere CR, Juvenale M, Mendes-Giannini MJ, et al. (2001) Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine 13: 248–52.
28. Calich VL, Singer-Vermes LM, Siqueira AM, Burger E, (1985) Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br. J Exp Pathol 66: 585–94.
29. Cano LE, Kashino SS, Arruda C, André D, Xidieh CF, et al. (1998) Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. Infect Immun 66: 800–806.
30. Calich VLG, Blotta MHSL (2005) Pulmonary paracoccidioidomycosis. In Fungal Immunology: From an Organ Perspective. Fidel PL, Huffnagle GB, eds. Springer, New York, NY. p. 201–228.
31. Chiarella AP, Arruda C, Pina A, Costa TA, Ferreira RCV, et al. (2007) The relative importance of CD4+ and CD8+ T cells in immunity to pulmonary paracoccidioidomycosis. Microbes Infect 9: 1078–88.
32. Calich VLG, Costa TA, Felonato M, Arruda C, Bernardino S, et al. (2008) Innate immunity to Paracoccidioides brasiliensis infection. Mycopathologia 165: 223–236.
33. Cano LE, Singer-vermes LM, Costa TA, Mengel O, Xidieh CF, et al. (2000) Depletion of CD8(+) T cells in vivo impairs host defense of mice resistant and susceptible to pulmonary paracoccidioidomycosis. Infect Immun 68: 352–359.
34. Nascimento FRF, Calich VLG, Rodriguez D, Russo M, (2002) Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J Immunol 168: 4593–4600.
35. Pina A, Bernardino S, Calich VLG, (2008) Alveolar macrophages from susceptible mice are more competent than those of resistant mice to control initial Paracoccidioides brasiliensis infection. J Leukoc Biol 83: 1088–99.
36. Pina A, Araujo EF de, Felonato M, Loures FV, Feriotti C, et al. (2013) Myeloid dendritic cells (DCs) of mice susceptible to paracoccidioidomycosis suppress T cell responses whereas myeloid and plasmacytoid DCs from resistant mice induce effector and regulatory T cells. Infect Immun 81: 1064–77.
37. Netto CF, Vegas VS, Scianname'A IM, Guarnieri DB, (1969) [The polysaccharidic antigen from Paracoccidioides brasiliensis. Study of the time of cultivation necessary for the preparation of the antigen]. Rev Inst Med Trop São Paulo 11: 177–81.
38. Feriotti C, Loures FV, Frank de Araújo E, da Costa TA, Calich VLG, (2013) Mannosyl-recognizing receptors induce an M1-like phenotype in macrophages of susceptible mice but an M2-like phenotype in mice resistant to a fungal infection. PLoS One 8: e54845.
39. Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VLG, (1992) The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J Med Vet Mycol 30: 261–264.
40. Cano LE, Vaz CA, Russo M, Calich VL, Singer-Vermes CIAM, (1995) Pulmonary paracoccidioidomycosis in resistant and susceptible mice: relationship among progression of infection, bronchoalveolar cell activation, cellular immune response and specific isotype patterns. Infect Immun 63: 1777–1783.
41. Adikari SB, Lian H, LinK H, Huang YM, XiaO BG, (2004) Interferon-γ-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis. Clin Exp Immunol 138: 230–236.
42. Ding AH, Nathan CF, Stuehr DJ, (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407–2412.
43. Braun D, Longman RS, Albert ML, (2005) A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106: 2375–81.
44. Cano Luz E, Gomez B, Brummer E, Restrepo A, Stevens DA, (1994) Inhibitory effect of deferoxamine or macrophage activation on transformation of Paracoccidioides brasiliensis conidia ingested by macrophages: reversal by holotransferrin. Infect Immun 62: 1494–1496.
45. Felonato M, Pina A, Araujo EF de, Loures FV, Bazan SB, et al. (2012) Anti-CD25 treatment depletes Treg cells and decreases disease severity in susceptible and resistant mice infected with Paracoccidioides brasiliensis. PLoS One 7: e51071.
46. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, et al. (2009) IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183: 2475–83.
47. Alberati-Giani D, Malherbe P, Ricciardi-Castagnoli P, Köhler C, Denis-Donini S, et al. (1997) Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells. J Immunol 159: 419–426.
48. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, et al. (2011) Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12: 870–8.
49. Fallarino F, Grohmann U, Puccetti P, (2012) Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur J Immunol 42: 1932–7.
50. de Castro LF, Ferreira MC, da Silva RM, Blotta MHSL, Longhi LNA, et al. (2013) Characterization of the immune response in human paracoccidioidomycosis. J Infect 67: 470–85.
51. Loures FV, Pina A, Felonato M, Calich VLG, (2009) TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 183: 1279–90.
52. Loures FV, Pina A, Felonato M, Araújo EF, Leite KRM, et al. (2010) Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect Immun 78: 1078–88.
53. Loures FV, Pina A, Felonato M, Feriotti C, de Araújo EF, et al. (2011) MyD88 signaling is required for efficient innate and adaptive immune responses to Paracoccidioides brasiliensis infection. Infect Immun 79: 2470–80.
54. Loures FV, Araújo EF, Feriotti C, Bazan SB, Costa TA, et al. (2014) Dectin-1 induces M1 macrophages and prominent expansion of CD8+IL-17+ cells in pulmonary paracoccidioidomycosis. J Infect Dis 210: 762–73.
55. Chen X, Wu X, Zhou Q, Howard OMZ, Netea MG, et al. (2013) TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T- cell phenotype in the inflammatory environment. J Immunol 190: 1076–84.
56. Chen X, Oppenheim JJ, (2014) Th17 cells and Tregs: unlikely allies. J Leukoc Biol 95: 723–731.
57. Arruda C, Vaz CAC, Calich VLG, (2007) Aseptic cure of pulmonary paracoccidioidomycosis can be achieved after a previous subcutaneous immunization of susceptible but not resistant mice. Microbes Infect 9: 704–13.
58. Arruda C, Franco MF, Kashino SS, Nascimento FRF, Fazioli R dos A, et al. (2002) Interleukin-12 protects mice against disseminated infection caused by Paracoccidioides brasiliensis but enhances pulmonary inflammation. Clin Immunol 103: 185–95.
59. Zelante T, Luca ADe, Bonifazi P, Montagnoli C, Bozza S, et al. (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37: 2695–706.
60. Bozza S, Zelante T, Moretti S, Bonifazi P, De Luca A, et al. (2008) Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol 180: 4022–4031.
61. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211–5.
62. Schubert MS, (2007) Allergic fungal sinusitis. Clin Allergy Immunol 20: 263–71.
63. Miceli MH, Maertens J, Buvé K, Grazziutti M, Woods G, et al. (2007) Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer 110: 112–20.
64. Gryschek RCB, Pereira RM, Kono A, Patzina RA, Tresoldi AT, et al. (2010) Paradoxical reaction to treatment in 2 patients with severe acute paracoccidioidomycosis: a previously unreported complication and its management with corticosteroids. Clin Infect Dis 50: e56–8.
65. Corvino CL, Mamoni RL, Fagundes GZZ, Blotta MHSL, (2007) Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis. Clin Exp Immunol 147: 483–90.